United States · FDA National Drug Code directory

Insulin Aspart Protamine and Insulin Aspart Mix 70/30

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
73070-203_885b9016-188e-469d-926d-ae8019b69612
Product NDC
73070-203
Form
INJECTION, SUSPENSION
Composition / generic term
insulin aspart
Labeler
Novo Nordisk Pharma, Inc.
Marketing category
BLA
Marketing start / end (source format)
20020911 / 20270630

Source-listed ingredients

  • INSULIN ASPART — 100 [iU]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 5 SYRINGE, PLASTIC in 1 CARTON (73070-203-15) / 3 mL in 1 SYRINGE, PLASTIC (73070-203-10) · 73070-203-15

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Insulin Aspart Protamine and Insulin Aspart Mix 70/30 — United States | Molindra Medicines